The mechanisms by which entire programmes of gene regulation emerged during evolution are poorly understood. Neuronal microexons represent the most conserved class of alternative splicing in vertebrates, and are critical for proper brain development and function. Here, we discover neural microexon programmes in non-vertebrate species and trace their origin to bilaterian ancestors through the emergence of a previously uncharacterized 'enhancer of microexons' (eMIC) protein domain. The eMIC domain originated as an alternative, neural-enriched splice isoform of the pan-eukaryotic Srrm2/SRm300 splicing factor gene, and subsequently became fixed in the vertebrate and neuronal-specific splicing regulator Srrm4/nSR100 and its paralogue Srrm3. Remarkably, the eMIC domain is necessary and sufficient for microexon splicing, and functions by interacting with the earliest components required for exon recognition. The emergence of a novel domain with restricted expression in the nervous system thus resulted in the evolution of splicing programmes that qualitatively expanded the neuronal molecular complexity in bilaterians.
N eural microexons are 3-27-nucleotide-long cassette exons that are activated during neuronal differentiation and generate protein isoforms with one to nine additional amino acids 1, 2 . These amino acids are often located on protein surfaces and can impact protein-protein interactions. Given their very short length, which is expected to preclude standard spliceosomal interactions needed for exon definition, the presence of extensive microexon programmes in vertebrates was surprising and mechanistically challenging. For most mammalian neural microexons, a single factor-the Ser/Arg repetitive matrix protein 4 (SRRM4; also known as nSR100)-is the major factor responsible for their inclusion 1 . Homozygous mutant mice deficient in Srrm4 show numerous neurodevelopmental defects affecting both the central and peripheral nervous system, and most die at birth 3 . Also, a mutation in Srrm4 has been linked to deafness in mice 4 . In contrast, heterozygous mutant mice expressing reduced levels of Srrm4 are viable, but show deficient neuronal excitability and synaptic transmission, as well as several autistic-like neurodevelopmental and behavioural abnormalities 5 . Misregulation of many of the orthologous microexons has also been linked to autism spectrum disorder in human subjects, correlating with reduced expression of SRRM4 1 . Consistent with their functional importance, among all classes of alternatively spliced exons, neural microexons are the most evolutionarily conserved and most likely to preserve the coding frame 1, 2 . However, their evolutionary origin is not known.
Results and discussion
Srrm4 was previously defined as a vertebrate-specific neural splicing regulator 6 , and target microexons were subsequently identified in all major vertebrate groups 1, 7 . To initially investigate the evolutionary origins of Srrm4 and neural microexons, we analysed tissue-specific RNA sequencing (RNA-Seq) data from the amphioxus Branchiostoma lanceolatum. This non-vertebrate species shares a general chordate body plan with vertebrates, but lacks many of their key traits. Remarkably, this analysis revealed a microexon programme comparable in size and neural specificity to that of zebrafish and mammals (Fig. 1a) . Furthermore, RNA-Seq data from multiple tissues from the centipede Strigamia maritima and fruit fly Drosophila melanogaster also revealed neural-specific microexon programmes in both species (Fig. 1a) . Zebrafish and mammalian neural microexons were largely shared, highlighting the unusually high conservation of this splicing programme within vertebrates (Fig. 1b) . Moreover, although most microexons are not conserved between vertebrates and non-vertebrates, several are shared among phyla, spanning 600 Myr of evolution (Supplementary Dataset 1). These include the autism-linked microexon in human CPEB4 (ref. 8 ), which is conserved across vertebrates and in the amphioxus and centipede Cpeb2/3/4 orthologue. These findings thus indicate that neural microexon programmes predate the last common ancestor of bilaterian animals.
To assess whether the non-vertebrate microexon programmes are regulated by a mechanism that is homologous to that of their vertebrate counterparts, we first sought evidence of Srrm4-dependent regulation by searching for UGC motifs, which are known to mediate direct Srrm4-dependent regulation of microexons in mammals 1, 4, 7, 9 . In all cases, we found enrichment of UGC-containing motifs in the upstream intron near the 3′ splice site (10-25 nucleotides) Articles NaTuRe eCology & evoluTIoN (Fig. 1c and Supplementary Fig. 1a ). Moreover, both vertebrate and non-vertebrate microexons were associated with strong 5′ splice sites, branch points and polypyrimidine tracts, but with weak 3′ splice site AG contexts ( Fig. 1d and Supplementary Fig. 1b ), although some of these signals were less pronounced for Drosophila and Strigamia, probably due to the differences in gene structure that favour intron definition mechanisms in these species. Given these sequence similarities between vertebrate and non-vertebrate species, we next asked whether the inclusion of Drosophila microexons could be promoted by heterologous expression of human SRRM4. Strikingly, overexpression of SRRM4 in SL2 Drosophila cells promoted the inclusion of two-thirds (18/27) of probed neural a, Phylogenetic tree of the main species used in the study and the presence of tissuespecific microexons in bilaterians. Alternatively spliced microexons are classified based on their enrichment in a particular tissue type: neural, muscle (skeletal and/or heart), visceral (liver, kidney, lung, salivary gland, digestive tract or Malpighian tubule), skin (or epidermis), gonads (female or male) and other (blood or early development). The number of neural microexons is indicated for each species. b, Evaluation of the conservation of human neural microexons in five other bilaterian species at different levels: gene (presence of the gene orthologue in the second species); exon (presence of the microexon orthologue in the same intron); AS (the orthologous microexon is also alternatively spliced); and neural (the orthologous microexon is also enriched in neural tissues). c, Enrichment of UGC motifs in the upstream intronic region of neural microexons. Length of sliding window: 17 nucleotides. Numbers of exons analysed per species are shown in brackets. The 'Data' subpanel (bottom) refers to the proportion of total sequences used for the RNA map at each position, as implemented by Matt 37 . d, Splicing regulatory features of neural microexons compared with longer alternatively spliced exons. 5′ss, splicing donor MaxEnt score; AG, splicing acceptor MaxEnt score; BP, best predicted branch point sequence score; Py, polypyrimidine tract sequence score. Median score differences per feature were normalized to the maximum difference observed per feature type across species. P values correspond to Mann-Whitney U-tests (*P < 0.01; **P < 0.001; ***P < 0.0001). See Supplementary Fig. 1b (Fig. 1e) . Furthermore, among all alternative exons enhanced by SRRM4 overexpression in SL2 cells, microexons were strongly enriched (26/66 versus 31/611; P = 4.9 × 10 −14 , Fisher's exact test). Thus, expression of human SRRM4 is sufficient to activate microexon splicing in non-vertebrate cells, as it is in non-neural mammalian cells ( Supplementary Fig. 1c ) 1 . These results prompted us to next search for factors with SRRM4-like activity in non-vertebrates. First, within vertebrates, based on phylogenetic and syntenic analyses, we identified Srrm2, Srrm3 and Srrm4 as paralogues resulting from the two rounds of whole-genome duplication that occurred at the base of the vertebrate clade 10 ( Fig. 2a  and Supplementary Fig. 2a) . The three paralogues presented as a mix-and-match of domain architecture, with domains ranging from shared across all three paralogues to paralogue specific ( Supplementary Fig. 2a) . Srrm2 (also known as SRm300 in humans and Cwc21 in yeast) is a pan-eukaryotic, broadly expressed splicing factor involved in both constitutive and alternative splicing [11] [12] [13] [14] . It is composed of an amino (N)-terminal 'cwf21 domain' that interacts with the core U5 small nuclear ribonucleoprotein (snRNP) spliceosomal protein Prp8, and a carboxy (C)-terminal region with an Arg/ Ser-rich (RS) domain and other repetitive features ( Supplementary  Fig. 2a ) 14, 15 . In contrast, Srrm4 contains an RS domain and an annotated domain of unknown function: Pfam15230 (hereafter, the 'enhancer of microexons' (eMIC) domain; Supplementary Fig. 2a) . Srrm3, which shares ~30% identity with Srrm4, contains both cwf21 and eMIC domains, which are found in Srrm2 and Srrm4, respectively ( Supplementary Fig. 2a) .
In contrast, in most non-vertebrate bilaterian animals, we found a single gene orthologous to the three vertebrate loci, which contains all Srrm2/3/4 domains ( Fig. 2b and Supplementary  Fig. 2a ). This gene shows greater sequence similarity to Srrm2 than to other family members (Fig. 2a) . However, in contrast with the three vertebrate paralogues, non-vertebrate Srrm2/3/4 genes nearly always generate multiple isoforms derived from several alternative initiation, splicing and polyadenylation events ( Fig. 2b-d) . Two of these events were of particular interest given their tissue specificity and level of evolutionary conservation: (1) an alternative promoter, which leads to the inclusion of a short motif conserved with vertebrate Srrm4 and is neurally enriched in both the centipede and the amphioxus ( Fig. 2c and Supplementary Fig. 2b ); and (2) an alternative last exon, which encodes the second half of the eMIC domain found in vertebrate Srrm3 and Srrm4 and is primarily expressed in neural tissues in all three studied non-vertebrate species ( Fig. 2d and Supplementary Fig. 2c,d ). In contrast with the Srrm3 and Srrm4 vertebrate paralogues, no tissue specificity was observed for total Srrm2/3/4 transcripts at the level of steady-state messenger RNA (mRNA) expression in non-vertebrates (Fig. 2e) . Together, these data suggest that neural regulation of microexons in non-vertebrates might be associated with alternative isoform usage of the single Srrm2/3/4 splicing factor.
To test this hypothesis, we performed heterologous expression experiments in HEK293 cells (which lack SRRM4 expression), using a measure of the inclusion levels of endogenous human neural microexons as a readout of SRRM4-dependent activity (Fig. 3a) . Expression of vertebrate (zebrafish) Srrm2 and Srrm4 served as negative and positive heterologous controls, respectively. Overexpression of four mRNA isoforms of the amphioxus Srrm2/3/4 locus combining the two alternative promoters (with 
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and without the cwf21 domain) and the two last exons encoding the alternative C termini ( Supplementary Fig. 3a ) revealed that the microexon regulatory activity depends exclusively on the presence of the full eMIC domain in the C terminus of the protein, as indicated by the inclusion pattern of MEF2C, CERS6, APBB1 and other analysed microexons ( Fig. 3a and Supplementary Fig. 3b ). Transfection of CG7971-A and CG7971-C-the equivalent isoforms of the Drosophila Srrm2/3/4 orthologue: refC and altC, respectively-confirmed that only the neural C terminus isoform (that is, containing the eMIC domain) promotes microexon inclusion ( Fig. 3a and Supplementary Fig. 3b ). To exclude a potential contribution of the alternative N termini of the Srrm2/3/4 proteins to microexon regulation, we performed RNA-Seq of stable HEK293 cell lines overexpressing the two different microexon-regulating amphioxus isoforms (with different N termini). Both isoforms commonly regulated all detected SRRM4-dependent microexons in HEK293 cells (Fig. 3b) . Furthermore, co-transfection of the amphioxus orthologue with minigenes containing vertebrate microexons and flanking intronic sequences with either wild-type or mutated UGC Srrm4-binding sites revealed the same dependency on this motif to mediate microexon inclusion as was previously described for the human protein (Fig. 3c ) 4, 7 . RNA-Seq from stable HEK293 cell lines overexpressing Srrm2/3/4 orthologues from the zebrafish and fruit fly confirmed the ability of eMIC-containing proteins to enhance genome-wide microexon inclusion, irrespective of their N termini ( Fig. 3d and Supplementary Fig. 3c,d ). Remarkably, this increased exon inclusion by eMIC-containing proteins affected up to 89.6% (163/182) of all neural microexon events with sufficient read coverage (Fig. 3d) . Moreover, unlike other neural splicing factors, the splicing effect of eMIC-containing proteins was extremely specific for short exons ( Fig. 3e and Supplementary Fig. 1c ).
To understand the history of the eMIC domain and its connection with neural microexon programmes, we next studied the phylogenetic distribution of this domain across metazoans. This analysis identified two independent loses since the bilaterian ancestors, in the nematode and platyhelminth clades ( Supplementary Fig. 4a ). Tissue-and cell-type-specific RNA-Seq data from Caenorhabditis elegans revealed only few neural microexons with no enrichment of the intronic UGC motif, consistent with the secondary loss of the eMIC domain ( Fig. 3f and Supplementary Fig. 4b,c) . Moreover, the absence of the eMIC domain in all non-bilaterian groups, as well xenacoelomorphs, precisely located its origin in nephrozoan ancestors. Consistently, RNA-Seq of the cnidarian Nematostella vectensis showed few microexons overall, and no enrichment in Elav1::mOrange-positive cells (that is, neuronal cells 16 ) versus other cell populations from transgenic polyps ( Fig. 3g and Supplementary  Fig. 4d,e) . As expected, transfection of the Nematostella Srrm2-like orthologue into HEK293 cells did not promote microexon inclusion (Fig. 3h, third lane) .
The results thus far suggest an evolutionary scenario in which the ancient Srrm2-like gene acquired the eMIC domain in bilaterian ancestors, conferring the ability to promote microexon inclusion. To test this hypothesis, we fused the region encoded by the last two exons of the human SRRM4 gene to the Nematostella Srrm2-like protein, and tested its regulatory activity in HEK293 cells ( Supplementary Fig. 3e ). Strikingly, this evolutionary chimera was able to promote microexon inclusion (Fig. 3h) . Furthermore, fusing the C-terminal region of human SRRM4 to other unrelated Ser/ Arg-repeat domain proteins (that is, SRRM1, SRSF1 and SRSF4) was sufficient to convert all of them into microexon regulators ( Supplementary Fig. 3f,g ). In fact, truncated versions of SRRM4 and SRRM3 consisting only of the two exons encoding the eMIC Red lines and asterisks mark point mutations in C3_M and C4_M constructs. b, Overexpression of human SRRM4-and SRRM3-derived constructs in HEK293 cells. c, Genome-wide effect of C4 (containing the eMIC domain, green) compared with FL_M (no eMIC domain, yellow) on microexon inclusion, measured as ΔPSI with respect to the control (stable line overexpressing GFP). d, AP-MS identification of protein interaction partners for specific regions SRRM4 (N-and C-terminus). The green box represents a set of proteins interacting with all constructs containing the eMIC domain. AvgSpec, average number of spectral counts across replicates; EJC, exon junction complex; RelSpec, relative spectral counts across each bait. Protein families: HNRNP, heterogenous nuclear ribonucleoprotein; RBP, RNA binding protein; SF, splicing factor; SR, Ser/Arg-rich protein; tri-snRNP, U4.U6/U5 small nuclear ribonucleoprotein. e, Co-immunoprecipitation assay showing the interaction of Flag-tagged eMIC-containing constructs with HA-tagged SF1 and U2AF2. f, The C3 peptide promotes pre-spliceosome (complex A) assembly on apbb1 RNA in functional U2 snRNP-containing nuclear extracts. HeLa cell nuclear extracts (NEs) were RNAse H inactivated with a control (Ctri) oligonucleotide or with oligonucleotides complementary to the 5′ end of U1 snRNA (U1i) or to the branch point recognition sequence of U2 snRNA (U2i), or depleted of U2 snRNP (U2Δ) and its control (CtrΔ). His-C3, His-tagged C3 peptide. The positions of the H and A complexes are indicated. g, The C3 peptide promotes pre-spliceosome (complex A) assembly on apbb1 microexon minigene RNA in a sequence-dependent manner. AG, 3′ splice site AG mutant; BP, branch point mutant; UGC, UGC mutant; WT, wild-type RNA. 'All' represents the mutation of all three sequence elements. h, Effect of adding C3 peptide on the protein composition of complexes assembled onto the apbb1 microexon RNA, as quantified by mass spectrometry. AvgSpec, average number of spectral counts per protein in complexes formed in the absence of C3 peptide; FC, fold change after the addition of C3 peptide. Proteins are coloured by protein complex, as per Supplementary Fig. 5c -e). Single point mutations in this region dramatically reduced the activity of the C-terminal peptides ( Supplementary Fig. 5a ), and combining only two point mutations resulted in complete loss of function of the mutant peptides (C3_M and C4_M in Fig. 4 and Supplementary Fig. 5 ).
To elucidate how the eMIC domain exerts its function at the biochemical level, we stably expressed different Flag epitope-tagged domains of SRRM4 in HEK293 cell lines and analysed their interaction partners by affinity purification coupled to mass spectrometry (AP-MS) ( Fig. 4d and Supplementary Fig. 5h ). The mutant lacking the eMIC domain (FL_M) interacts mainly with members of the exon junction complex and associated factors, such as EIF4A3, PNN, ACIN1 or RNPS1. RNPS1 has recently been identified as a major SRRM4 interactor in a genome-wide screen for factors regulating microexon splicing 9 . In contrast, the C-terminal region interacts specifically with early spliceosomal factors, particularly proteins that function in the recruitment of U2 snRNP to the branch site region of pre-mRNA. Indeed, only SF1 and U2AF, which are among the earliest factors known to function in spliceosome assembly, were found to interact with all constructs containing an eMIC domain ( Fig. 4d and Supplementary Fig. 5f ,h), which we validated by co-immunoprecipitation and western blot analysis ( Fig. 4e and Supplementary Fig. 5g ). These interactions thus suggest a role for the eMIC domain at the initial steps of spliceosome assembly. Consistent with this, in vitro spliceosome assembly assays using HeLa cell nuclear extracts and a pre-mRNA transcript containing the six-nucleotide-long apbb1 microexon revealed an ATP-and U2 snRNP-dependent complex ( Fig. 4f and Supplementary Fig. 6a ) that was enhanced in nuclear extracts obtained from cells expressing either the full-length SRRM4 or C4, as well as by the addition of purified recombinant C4/C3 peptides in a branch point-and UGCdependent manner ( Fig. 4g and Supplementary Fig. 6b,c) . The effect of the peptide was independent of the 3′ splice site AG (Fig. 4g) , and was also detected on a substrate lacking a functional 5′ splice site ( Supplementary Fig. 6c,d) , suggesting that the eMIC domain promotes early steps of 3′ splice site recognition. Consistent with the results in cell culture (Figs. 3 and 4) , different wild-type versions of both human-and zebrafish-derived C3 and C4 peptides were active in promoting spliceosomal A complex formation in vitro ( Supplementary Fig. 6e ), but mutant peptides displayed reduced or no activity ( Supplementary Fig. 6f ). Mass spectrometry analysis of complexes assembled in vitro on wild-type and UGC-mutated apbb1 RNAs confirmed that eMIC-containing peptides enhanced the formation of early stages of splicing complex formation by promoting the recruitment of SF1, U2AF and U2 snRNPs (Fig. 4h,  Supplementary Fig. 7 and Supplementary Dataset 2) 7, 17 . The effect of C3 peptide requires SF1 ( Supplementary Fig. 6h ), indicating that the peptide does not overcome early BP recognition by this factor. Collectively, these experiments provide biochemical evidence that the eMIC domain is crucial for microexon inclusion by promoting the earliest stages of spliceosome assembly.
In summary, our comparative approach has uncovered a genomic novelty in the Srrm2-like locus of bilaterian ancestors by which an alternative splicing event in a core splicing factor generated a new protein domain whose associated biochemical function enabled the specific recognition and inclusion of microexons. Therefore, unlike most reported cases (for example, refs. [18] [19] [20] ), this neofunctionalization occurred not via gene duplication but through novel domain emergence and alternative splicing of an ancestral locus. Intriguingly, we have not found sequence similarity between the eMIC domain and any other characterized protein domains in any species, suggesting de novo evolution as a specialized type of RS domain. Besides, secondary-structure predictions of this domain indicate an unstructured conformation. Description of its precise activity in contacting early spliceosomal components thus remains outstanding.
The 600-Myr-old biochemical function provided by the eMIC domain qualitatively expanded the regulatory landscapes of animal proteomes by enabling the evolution of transcriptomic elements (microexons), most of which could not have been previously recognized by the cellular machinery. The restriction of the eMICencoding isoforms to the nervous system facilitated the expansion and specialization of neuronal proteomes by innovations in a set of genes involved in diverse cellular functions, including vesicle transport and release, cytoskeleton organization, and chromatin regulation, among others 1, 5, 21, 22 . During vertebrate evolution, duplication and subfunctionalization of a single ancestral Srrm2/3/4 gene gave rise to three splicing factors: SRRM2, SRRM3 and SRRM4. SRRM3 and SRRM4 became specifically expressed in the nervous system and evolved to provide critical roles in nervous system development and function-a feature that is underscored by SRRM4 disruption causing nervous system developmental defects and neurological disorders.
Methods
RNA-Seq datasets. All RNA-Seq samples used in the current study are listed in Supplementary Dataset 3. For the human and mouse, we used publicly available data provided in VastDB (http://vastdb.crg.eu). For the zebrafish Danio rerio, amphioxus B. lanceolatum, worm C. elegans and fruifly D. melanogaster, we collected publicly available RNA-Seq data from the National Center for Biotechnology Information (NCBI) Short Read Archive (SRA). For the centipede S. maritima, we performed tissue dissections in adult specimens for nerve cords, heads, muscles, Malpighian tubules, male gonads and salivary glands. RNA was extracted using TRIzol (Ambion) following the manufacturer's instructions. Ribosomal RNA-depleted, strand-specific libraries were built and sequenced using Illumina HiSeq 2500 at the Centre for Genomic Regulation (CRG) Genomics Unit. An average of 140 million 75-nucleotide paired-end reads were generated per sample. Raw data were submitted to the Sequence Read Archive (accession number SRP149913).
Computational analysis of tissue-specific microexons. The toolset vast-tools 1, 23 was used for identification of microexons and quantification of their inclusion levels (using the metric 'percent spliced in' (PSI)) from RNA-Seq data from different cell and tissue types in each of the seven species analysed (Supplementary Dataset 3). In brief, vast-tools uses different modules to identify and quantify all major types of alternative splicing, including simple and complex cassette exon events, retained introns, alternative acceptor and donor site choices, and microexons 1, 23 . It has been used to analyse alternative splicing in multiple species, providing high validation rates by reverse transcription PCR 1, 3, 5, 7, [23] [24] [25] [26] [27] [28] [29] , especially for microexons 1 . In particular, the microexon module compiles all annotated and de novo-identified 3-15-nucleotide microexons and profiles their inclusion levels using exon-microexon-exon junction read counts as support for inclusion, instead of the standard exon-exon junctions (details in ref. 1 Following previous studies 23 , we defined as 'alternatively spliced' (Fig. 1b ) those microexons with 10 ≤ PSI ≤ 90 in at least 10% of the samples with sufficient read coverage (vast-tools score LOW or higher; for details, see https://github.com/ vastgroup/vast-tools/blob/master/README.md) or a range of PSI values ≥ 25 across the same samples. To identify microexons that were specifically enriched (or depleted) in neural tissues, we required a ΔPSI ≥ 15 (or ≤ −15) between the neural and every other tissue with sufficient read coverage. Microexons that presented equivalent enriched inclusion patterns for any other tissue were grouped together according to the tissue type (Fig. 1a) : muscle (skeletal and/or heart), visceral (liver, kidney, lung, digestive tract, Malpighian tubule or salivary gland), skin (epidermis or skin), gonads (testis, ovary or female/male gonads) or other (early development or immune/blood tissues). For all analyses, we required that the microexon had sufficient read coverage in at least 4 different tissues (from a total of 12 tissues in vertebrates and 6-8 in non-vertebrates; Supplementary Dataset 3).
Microexon orthology analysis.
To identify orthologous microexons among the analysed species, we followed a similar methodology as previously described 29 ,
fly, taking into account the different number of whole-genome duplication events experienced by each group (two for the human and mouse, and three for the zebrafish). For this purpose, we used orthology information from OMA 30 , Multiparanoid 31 and pairwise BlastP between all six species, employing the longest protein-coding isoform for each gene. Then, for each gene from species A versus each gene from species B, a combined orthology score was derived for the gene pair based on the information provided by the different sources:
(1) OMA: +1 if they belonged to the same OMA cluster. (2) Multiparanoid: +1 if they belonged to the same Multiparanoid cluster and both genes had a Multiparanoid score ≥0.5. (3) BlastP: +1 if hit spA=>spB ≤ R spB /min(R spA ,R spB ) and hit SpB=>SpA ≤ R spA / min(R spA ,R spB ), or +0.5 if hit spA=>spB ≤ R spB /min(R spA ,R spB ) and hit SpB=>SpA = 1 + (R spA /min(R spA ,R spB )), where hit spA=>spB is the rank of the gene pair in the BlastP output of species A against species B, hit spB=>spA is the rank in the reciprocal blast (that is, species A against species B), R spA and R spB are the levels of ancestral ploidy in species A and B (1× in non-vertebrates, 4× in mammals and 8× in zebrafish), and min(R spA ,R spB ) is the lowest of these two values.
Therefore, each pair of genes from any two species may have a maximum orthology score of 3. Next, gene orthology clusters were built in an iterative manner with subsequently less stringent cut-offs ('ConfLevel' in Supplementary Dataset 4), and aiming to minimize the number of false positive orthology assignments.
For iteration 1, only pairs of genes with an orthology score of 3 were considered orthologues and assigned to the same cluster. When a pair of orthologous genes belonged to two different clusters, the two clusters were merged. However, to avoid artifactual merging, the two clusters were merged only if the total ploidy complement of the merged cluster was closer to the idealized situation (4, 4, 8, 1, 1 and 1 for the human, mouse, zebrafish, amphioxus, fruit fly and centipede, respectively) than each of the clusters individually. Note that this approach is conservative with regards to false positive orthology calls. At this stage, we also grouped clusters based on previously reported ohnology relationships 32 , using their intermediate confidence level.
Iteration 2 was aimed at filling the potential gaps in the idealized ploidy complement. For each cluster generated in iteration 1, we searched for potential orthologues only in the species without an assigned orthologue or with a number of members lower than its ancestral ploidy (in the case of vertebrates). To assign novel orthologues to a gene cluster, we required an orthology score against any of the members of the clusters of ≥2. Two different clusters could be merged if the missing orthologue already belonged to another cluster, with the limitations described above.
Iteration 3 was performed following a similar process to iteration 2, but filling potential gaps by requiring an orthology score of ≥1.5 and not allowing cluster merges.
Finally, to generate clusters based on less supported orthology relationships, genes that were not assigned to any cluster were re-evaluated using iterations 1 and 3, but using a minimal orthology score of ≥2.5 (iteration 4) and 1.5 (iteration 5), respectively. Clusters of gene orthologues are provided as Supplementary Dataset 4.
Then, for each gene cluster in which at least one human gene hosts a neuralenriched microexon, we aligned all pairs of proteins from each species using MAFFT 33 . Intron positions and their corresponding phases for each species' protein were integrated into the resulting pairwise protein alignment to introduce the exonintron structure information 34 . A microexon in a given species A was considered to be conserved in species B if: (1) their upstream and downstream constitutive exons had at least 20% protein similarity with the corresponding exons in species B; and (2) their corresponding flanking upstream and downstream intron positions showed the same phase and an offset of no more than five residues in the protein alignment. Moreover for human and mouse microexons, additional homology information was obtained using liftOver (http://genome.ucsc.edu/cgi-bin/hgLiftOver) and curated manually. Finally, homologous microexon clusters were built using a guiltby-association approach with all of the homologous microexons identified between each pair of species (that is, if the microexon was considered conserved between species A and B and A and C, a cluster for species A, B and C was produced). Clusters for human neural microexons that were found to be conserved in at least one other studied species are provided in Supplementary Dataset 1.
Analysis of sequence features associated with neural microexons. For each species, we compared different sequence features of neural-enriched microexons against a set of 1,000 random longer (>27 nucleotides), non-neural alternative exons, as a control. We calculated the strength of the donor and acceptor splice sites (5′ splice site and 3′ splice site/AG, respectively) according to maximum entropy score models 35 . For branch point and polypyrimidine tract score calculation, we employed the best predicted branch point for each exon 36 . To test for differences in the median of the scores for each feature between the two groups (neural microexons versus longer non-neural alternative exons), we used Mann-Whitney U-tests. To generate the RNA maps in Fig. 1c and Supplementary   Figs. 1a and 4c , we used the rna_maps function from Matt 37 , using sliding windows of 17 nucleotides. Searches were restricted to the microexon, the first and last 150 nucleotides of the upstream and downstream intron (or total intron length if shorter than 150 nucleotides) and 13 nucleotides into the upstream and downstream exons. Below the main RNA map, we also displayed the percentage of the data used at every nucleotide position, to graphically depict the number of exons being analysed for each region.
Stable heterologous expression of human SRRM4 in Drosophila SL2 cells.
Myc-tagged human SRRM4 was cloned into MT-STABLE1 vector 38 (provided by J. D. Sutherland) in the position of the puromycin resistance gene by NheI/ XhoI restriction enzyme digestion. MT-STABLE1-myc-SRRM4 and empty MT-STABLE1 (used as a negative control) were co-transfected into D. melanogaster SL2 cells, together with the resistance plasmid Ac5-puro in a 9:1 ratio using Effectene Transfection Reagent (Qiagen), following manufacturer's instructions. Cells were maintained under selection for 48 h after transfection by adding 5 μg ml −1 puromycin, reaching a stable population of >90% green fluorescent protein (GFP)-positive cells. Myc-SRRM4 expression was induced with 500 μM copper sulfate for 4 d. Total RNA was extracted from SRRM4-expressing and control cells using an RNeasy Plus Mini kit (Qiagen), following manufacturer's instructions, and subjected to polyA-selected RNA-Seq at the CRG Genomics Unit. An average of 66 million 125-nucleotide paired reads were generated for each sample (Supplementary Dataset 3) . The impact of SRRM4 expression on exon inclusion levels was calculated using vast-tools as the ΔPSI between the test and control samples. Only exons and microexons with coverage scores of LOW or higher in both samples are represented in Fig. 1e .
Search for Srrm4 orthologues and generation of multi-species alignment.
Srrm4 orthologues for all organisms included in Fig. 2 and Supplementary Fig. 2a-c were identified by tblastn searches against NCBI and EnsemblMetazoa databases (Supplementary Dataset 5). We followed the conventional gene nomenclature from the community studying whole-genome duplications in vertebrates (that is, naming the non-vertebrate orthologous genes to the three vertebrate ohnologues (Srrm2, Srrm3 and Srrm4) as Srrm2/3/4). To generate the protein alignment to build the phylogenetic tree in Fig. 2a , Srrm2/3/4 orthologues from representative species of major metazoan groups were selected, and Srrm1 orthologues from the same species were used as outgroups. Protein sequence alignment was performed using MUSCLE 39 . The phylogenetic tree was built using Mr. Bayes 40 , using the matrix VT 41 and allowing for different aminoacid change rates (+G improvement), as recommended by ProtTest 42 , and visualized with FigTree version 1.4.3 (http:// tree.bio.ed.ac.uk/software/figtree). Branch support values (posterior probabilities) were calculated for half-million iterations in Mr. Bayes. For ancestral gene structure reconstruction, exon-intron structures of Srrm2/3/4 orthologues were assessed using GeneWise 43 , and the resulting protein sequences were aligned taking into consideration intron positions and phases 34 . For alignment of the alternative N-and C-terminal regions in bilaterians, we searched for the presence of the conserved motifs in the genomic regions of Srrm4 orthologues using tblastn, since they are often not present in the annotation. Protein sequence alignments of these protein regions (Fig. 2c,d ) were done using MUSCLE and visualized using MSAViewer 44 . Information-content sequence logos were generated using Skylign 45 .
Quantification of expression and alternative isoform usage of Srrm2/3/4 orthologues. To estimate the percentage of transcripts from the Srrm2/3/4 locus that use the alternative first and last exons in non-vertebrate bilaterians, we mapped RNA-Seq data from different tissues to isoform-specific exon-exon junctions. For quantification of amphioxus alternative C terminus usage, we used the PSIs as quantified by vast-tools, since this is a simple exon-skipping event in this species that can be readily measured with this pipeline. For quantification of the alternative promoter in amphioxus and Strigamia, and the alternative last exon of Drosophila, the number of reads mapping to all of the potential donor or acceptor sites from the reference upstream or downstream exon, respectively, were obtained from the eej2 output of vast-tools, which reports the read counts for all possible exon-exon junction combinations 1 . In the case of the alternative C-terminal isoform of Strigamia, we manually mapped reads to all of the possible exon-exon junctions that could take place within this terminal region. In all cases, we displayed the percentage of reads mapping the exon-exon junction supporting the neural isoform (blue lines in Fig. 2c,d ) over the total number of reads across all competing junctions. For gene expression analysis of Srrm2/3/4 homologues, gene counts reported by vast-tools were used as input for edgeR 46 , which provided the total counts per million (CPM) as a measure of the gene expression per species. To normalize the expression across the different orthologues, CPM values were converted to z scores within each gene and species.
Generation of constructs used for HEK293 heterologous expression experiments.
Full-length open reading frames for each tested isoform were amplified from complementary DNA (cDNA) from various sources. 6xHistidine was tagged at the N terminus, cloned into pcDNA3.1(-), and sequence verified for transient overexpression in HEK293 cells. Protein chimeras fusing the C-terminal region of human SRRM4 to several proteins (N. vectensis Srrm2, zebrafish Srrm1
Articles NaTuRe eCology & evoluTIoN and Srrm2, and human SRSF1 and SRSF4) were performed using standard restriction/ligation methods (all primers are provided in Supplementary Dataset 6). Point mutants of C4 and C3 peptides and the full-length SRRM4 lacking the eMIC domain were generated by site-directed mutagenesis (inverse PCR of plasmids encoding the wild-type sequences) using oligos as recommended by NEBaseChanger (http://nebasechanger.neb.com).
Cloning of splicing reporters. Minigenes encompassing 'exon-intronmicroexon-intron-exon-first 25 nucleotides of the downstream intron' were constructed for the asap1 and apbb1 zebrafish microexons. The corresponding genomic regions were cloned using KpnI and NotI restriction sites in between PT1 and PT2 sequences, for detection by reverse transcriptase PCR after transfection 47 , and under a Cytomegalovirus promoter. To facilitate cloning, introns were shortened, resulting in constructs with the following structure (italics indicate intronic sequences): asap1: 87 nucleotides-250 nucleotides XhoI 250 nucleotides-9 nucleotides-163 nucleotides HindIII 66 nucleotides-101 nucleotides-25 nucleotides (the endogenous upstream and downstream introns are 2,032 and 1,578 nucleotides long, respectively); apbb1: 128 nucleotides-279 nucleotides-6 nucleotides-250 nucleotides PstI 230 nucleotides-115 nucleotides-25 nucleotides (the endogenous upstream and downstream introns are 279 and 1,784 nucleotides long, respectively).
The splicing profile of the minigenes was assessed using PT1 and a reverse primer in the last exon for the asap1 minigene, and with zebrafish specific primers in the first and last exons for the appb1 minigene.
Transient heterologous expression of Srrm4 orthologues. HEK293 cell transfections were performed using Lipofectamine 2000 (Invitrogen), following the manufacturer's instructions, in 6-well plates with 1 μg of expression plasmid. For minigene analysis, 10 ng of plasmid bearing the minigene was co-transfected with the expression construct. Cell pellets were collected 24 h after transfection. RNA was extracted using the RNeasy Plus Mini kit (Qiagen) and cDNA was generated using SuperScript III (Thermo Fisher Scientific) following manufacturer's instructions. Reverse transcriptase PCRs of microexon events were performed using primers annealing to the flanking upstream and downstream constitutive exons (all primer sequences are provided in Supplementary Dataset 6).
Generation of HEK293 Flp-In T-REx stable cell lines used for RNA-Seq.
Flp-In (Thermo Fisher Scientific) expression plasmids-pcDNA5 and pcDNA5 containing GFP, 3xFlag-tagged human SRRM4, FL_M and C4; zebrafish Srrm2, Srrm3 and Srrm4; and Drosophila CG7971-C or amphioxus Srrm2/3/4 isoforms containing the eMIC domain-were generated using standard restriction/ ligation methods (all primers are provided in Supplementary Dataset 6). For each construct, tetracycline inducible Flp-In T-REx 293 stable cell lines were generated by transfecting 400 ng of the pcDNA5 plasmid with 3.6 μg of pOG44 Flp-recombinase expression plasmid (V600520; Thermo Fisher Scientific) using Lipofectamine 2000 (Invitrogen). Cells containing stably integrated constructs were selected in 100 μg ml −1 Hygromycin B until visible colonies were formed, and individual colonies were expanded and stored. For each protein, two clones from independent colonies were screened for transgene expression by quantitative PCR before and 24 h after induction with 1 μg ml −1 doxycycline. For each protein, we selected the clone with the closest transcript levels to the other lines for RNASeq (RNA-Seq-based quantifications are provided in Supplementary Fig. 3d ). RNA coming from a well of a 6-well plate for every line was extracted after 24 h induction with doxycycline, using the RNeasy Plus Mini kit (Qiagen). RNA quality was checked using Bioanalyzer (Agilent), and strand-specific Illumina libraries were prepared and sequenced at the CRG Genomics Unit. An average of 60 million 125-nucleotide paired-end reads were generated for each sample (Supplementary  Dataset 3) . Raw RNA-Seq data were processed with vast-tools, and the impact on the endogenous human microexons was compared between the control and the different lines using the module compare.
Western blot analysis of FLAG-tagged SRRM4 constructs. Total cellular proteins were extracted from HEK293 Flp-In cells growing in a 6-well plate after 24 h induction with 1 μg ml −1 doxycycline, using 2× Laemmli buffer (125 mM Tris-HCl pH 6.8, 20% glycerol, 4% sodium dodecyl sulfate (SDS)). Cell lysates were subjected to sonication (5 × 30 s pulses with 30 s between them). BCA assay (Thermo Fisher Scientific) was used to determine the protein concentration. Western blots were performed using 10% SDS-polyacrylamide gels, and the nitrocellulose membranes were probed with antibodies against FLAG-tag anti-FLAG M2 (F1804; SigmaAldrich) and α-tubulin (3873S; Sigma-Aldrich) at a dilution of 1:1,000 in TBST 3% milk. Immunolabelling was detected by enhanced chemiluminiscence (Luminata Forte Western HRP substrate; WBLUC0100; Merck) and visualized with a digital luminescence image analyser (Amersham Imager 600).
Analysis of target exon length distribution for tissue-specific splicing factors.
Published RNA-Seq datasets for Nova1/2, Rbfox1/2/3, Srrm4 and Esrp1/2 knockout or knock-down experiments (Supplementary Dataset 3) were analysed using vast-tools to calculate exon inclusion changes dependent on the depletion of these splicing factors. The top 100 exons regulated by each protein family (that is, having the highest absolute ΔPSI compared with the control condition) were used for exon size distribution calculation, as depicted in Fig. 3e .
Cell dissociation and RNA isolation of sorted populations from N. vectensis. Neuron-specific transgenic NvElav1::mOrange polyps of N. vectensis 16 were spawned and reared as previously described 48 . Several hundred mOrange-positive primary polyps (12-14 d old) were dissociated at 37 °C for ~30 min in calcium-and magnesium-free Nematostella medium containing ethylenediaminetetraacetic acid (EDTA) and 0.25% trypsin. Single-cell suspensions were then stained at room temperature with Hoechst 33342 and 7-aminoactinomycin D to exclude debris and non-viable cells by fluorescence-activated cell sorting. Doublet/multiplet exclusion was performed by plotting Hoechst-H versus Hoechst-A. Approximately 650,000 viable mOrange-positive or -negative cells were sorted into calcium-and magnesium-free Nematostella medium containing 0.5% bovine serum albumin (BSA; pH 7.8) using a BD FACSAria maintained at 4 °C throughout the procedure. Cells were collected by centrifugation (800g) for 10 min at 4 °C and resuspended in TRIzol LS reagent (3:1 reagent-to-sample ratio) in 4 independent sorts. Total RNA from the positive and negative populations was isolated using Direct-zol RNA MicroPrep columns (Zymo Research) following the manufacturer's instructions, and the RNA quality was assessed using a Bioanalyzer (Agilent). Two replicates of the elav+ and elav− samples with an RNA integrity number of ≥9.0, each consisting of pooled RNA extractions from two different sorting experiments, were sequenced using an Illumina HiSeq 2500 at the CRG Genomics Unit, generating an average of 65 million 126-nucleotide paired-end, strand-specific reads per sample (Supplementary Dataset 3) . Raw fastq data were processed using vast-tools and the number of differentially regulated microexons between the elav+ and elav− fractions obtained by employing vast-tools compare with default parameters (ΔPSI ≥ 15 and pairwise differences between all replicates of ΔPSI ≥ 5). VastDB libraries for N. vectensis can be downloaded from the vast-tools website ('Nve'; GCA_000209225; http://vastdb.crg.eu/libs/vastdb.nve.10.05.18.tar.gz).
Generation of HEK293 Flp-In T-REx stable cell lines used for mass spectrometry. Flp-In (Thermo Fisher Scientific) compatible expression plasmids (5′ pcDNA5-BirA*-FLAG, modified from V6010-20; Thermo Fisher Scientific) containing full-length and mutant human SRRM4 and SRRM3 cDNA constructs were generated using Gateway cloning (Thermo Fisher Scientific). For each bait protein, tetracycline-inducible Flp-In T-REx 293 stable cell lines were generated by transfecting 200 ng of the pcDNA5-BirA*-FLAG bait construct with 2 μg of pOG44 Flp-recombinase expression plasmid (V600520; Thermo Fisher Scientific) using jetPRIME transfection reagent (CA89129-924; Polyplus). Cells containing stably integrated constructs were selected in 200 μg ml −1 Hygromycin B until visible colonies were formed, and passaged to a 150 mm plate. Stable HEK293 Flp-In T-REx cell lines expressing BirA*-FLAG, BirA*-FLAG-NLS or FLAG without a bait cDNA were generated in parallel to be used as negative controls. For FLAG affinity purification experiments, all HEK293 Flp-In stable cell lines, including controls, were grown to ∼70% confluency and induced for 24 h with 1 μg ml −1 tetracycline to express the BirA*-FLAG-tagged bait protein. After induction, each 150 mm plate was harvested by scraping in 1 ml ice-cold phosphate buffered saline, pelleted and then frozen at −80 °C until purification.
Sample preparation for FLAG AP-MS. FLAG AP-MS experiments were performed in two biological replicates, essentially as described previously 49 , with slight modifications. In brief, cell pellets for each bait protein were lysed in ice-cold TAP Lysis Buffer containing 50 mM HEPES-NaOH (pH 8.0), 100 mM NaCl, 2 mM EDTA and 10% glycerol with freshly added 0.1% NP-40, 1 mM dithiothreitol (DTT), 1 mM phenylmethylsulfonyl fluoride and 1:500 Protease Inhibitor Cocktail (P8340; Sigma-Aldrich) at a 1:4 pellet weight-to-volume ratio (for 0.1 g, 0.4 ml of lysis buffer was added). Resuspended pellets were placed on dry ice for 5 min and thawed in a 37 °C water bath until only a small ice pellet remained. Samples were quickly moved back onto ice and sonicated with 3 10 s bursts with 2 s rest at an amplitude of 35%. To solubilize chromatin and reduce the detection of interactions mediated by RNA or DNA, 250 U of Benzonase Nuclease (E8263; Sigma-Aldrich) was added to each tube and incubated for 30 min with rotation at 4 °C. Lysates were cleared by centrifugation at 20,000g for 20 min at 4 °C, then transferred to tubes containing 25 μl of 50% magnetic anti-FLAG M2 slurry beads (M8823; Sigma-Aldrich) prewashed in lysis buffer. FLAG immunoprecipitation was allowed to proceed for 3 h at 4 °C with rotation. After incubation, beads were pelleted by centrifugation (1,000 r.p.m. for 1 min) and magnetized to aspirate the unbound lysate. The beads were then demagnetized and washed with 1 ml of lysis buffer, and the total volume (with beads) was transferred to a new tube. Beads were washed once more with 1 ml of lysis buffer followed by 1 wash with 50 mM ammonium bicarbonate (ABC) at pH 8. All wash steps were performed on ice using cold lysis buffer and ABC. After the final wash, any residual ABC was aspirated from the beads, and 1 μg of trypsin (T6567; Sigma-Aldrich) in 10 μl of ABC was added to each tube. The samples were incubated at 37 °C overnight with rotation. The following morning, beads were magnetized, and the supernatant was transferred to a new tube. Another 250 ng of trypsin was added to each supernatant in 5 μl of ABC (to a total volume of 15 μl) and further digested with rotation for another 4 h at 37 °C. Samples were acidified with formic acid to a final concentration of 2.5% and dried in a centrifugal evaporator.
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NaTuRe eCology & evoluTIoN AP-MS data acquisition. Data acquisition for the AP-MS experiments was performed as described previously 50 . Digested peptides were dissolved in 5% formic acid in a volume in which 6 μl contained purified material from onequarter of a 150 mm plate. For each sample, 5 μl of each sample was directly loaded at 800 nl min −1 onto a 15 cm 100-μm-ID emitter tip packed in house with 3.5 μm ReproSil C18 (Dr. Maische). The peptides were eluted from the column at 400 nl min −1 over a 90 min gradient generated by a 425 NanoLC, and analysed on a TripleTOF 6600 instrument (AB Sciex). The gradient started at 2% acetonitrile with 0.1% formic acid and increased to 35% acetonitrile over 90 min, followed by 15 min at 80% acetonitrile, then 15 min at 2% acetonitrile for a total of 120 min. To minimize carryover between each sample, the analytical column was flushed for 1 h at 1,500 nl min −1 with an alternating sawtooth gradient from 35-80% acetonitrile, holding each gradient concentration for 5 min. The analytical column and instrument performance were verified after each sample by analysing 30 fmol BSA tryptic peptide digest with 60 fmol α-casein tryptic digest with a short 30 min gradient. Mass spectroscopy mass calibration was performed on BSA reference ions between each sample. Acquisition was in the data-dependent mode and consisted of 1 250 ms MS1 TOF survey scan from 400-1,250 Da, followed by 20 100 ms MS2 candidate ion scans from 100-2,000 Da in high-sensitivity mode. Only ions with a charge of 2+ to 4+ that exceeded a threshold of 200 counts s −1 were selected for fragmentation, and former precursors were excluded for 10 s after 1 occurrence.
AP-MS data analysis. MS data were stored, searched and analysed using the ProHits laboratory information management system platform 51 . The WIFF data files were converted to MGF format using WIFF2MGF and subsequently converted to an mzML format using ProteoWizard (3.0.4468) and the AB SCIEX MS Data Converter (version 1.3 beta). The mzML files were searched using Mascot (version 2.3.02) and Comet (2014.02 rev.2). The results from each search engine were jointly analysed through the Trans-Proteomic Pipeline 52 via the iProphet pipeline 53 . The spectra were searched against a total of 72,482 proteins consisting of the NCBI human RefSeq database (version 57; 9 August 2016; forward and reverse sequences) supplemented with 'common contaminants' from the Max Planck Institute (http://141.61.102.106:8080/share.cgi?ssid=0f2gfuB) and the Global Proteome Machine (http://www.thegpm.org/crap/index.html), as well as sequences from common fusion proteins and epitope tags. The database parameters were set to search for tryptic cleavages, allowing up to 2 missed cleavage sites per peptide, an MS1 mass tolerance of 40 ppm with charges of 2+ to 4+, and an MS2 mass tolerance of ±0.15 amu. Asp/Glu deamidation and methionine oxidation were selected as variable modifications. A minimum iProphet probability of 0.95 was required for protein identification with a minimum number of two unique peptides required for protein interaction scoring (Supplementary Dataset 2) . Significance Analysis of INTeractome (SAINTexpress version 3.6.1) 54 was used as a statistical tool to calculate the probability value of each potential interaction from background contaminants. Briefly, our experimental design included specific negative controls (BirA*-FLAG, BirA*-FLAG-NLS and FLAG), each run in several biological replicates (12 in total). Each biological replicate of a bait was analysed independently against these controls before averaging of the score values and assessment of the Bayesian false discovery rates (FDRs) 54 . High-confidence interactions are those with FDR ≤ 1%.
Co-immunoprecipitation experiments. HA-tagged constructs were transiently transfected into HEK293 Flp-In cells grown in 6-well plates using Lipofectamine 2000 (Invitrogen), following manufacturer's instructions. After 24 h, cells were treated with 0.2 μg ml −1 (C4 and Min4) or 10 μg ml −1 doxycycline (C4_M). Then, 24 h later, they were harvested in cold phosphate buffered saline and lysed in 250 μl cold 1× TAPS buffer (50 mM HEPES pH 8.0, 100 mM NaCl, 10% glycerol, 2 mM EDTA, 0.1% NP-40, 1 mM DTT and protease inhibitors). Lysates were subject to sonication (7 × 1 s pulses with 1 s in between at 30% power). For nuclease digestion, 250 U Benzonase was added, and lysates were incubated at 4 °C for 60 min with rotation. Lysates were cleared in a microcentrifuge by spinning at 15,000g for 10 min at 4 °C. Clarified lysates were pre-cleared with 10 μl Dynabeads Protein G (Thermo Fisher Scientific) for 30 min at 4 °C. Anti-HA (for SF1 and U2AF2) or anti-Flag (to test for U2AF1 interaction) immunoprecipitation was performed using magnetic Dynabeads Protein G (Thermo Fisher Scientific) complexed with Rat anti-HA antibody (Roche) or mouse anti-Flag M2 antibody (Sigma-Aldrich). Antibody was incubated with lysates for 1 h at 4 °C, followed by incubation with washed Dynabeads Protein G for 1 h at 4 °C with rotation. Following the incubation step, the complexes were washed three times with cold 1× TAPS buffer. Elution was performed by boiling in 1× Laemmli buffer at 95 °C for 5 min.
In vitro spliceosome assembly assays. Cy5-CTP/Cy5-UTP-labelled RNAs were in vitro transcribed from PCR products using a MEGAscript T7 Transcription kit (Ambion). The sequences of the apbb1 and asap1 RNAs used are provided in Supplementary Dataset 6. IgM bears the 3′ 70 nucleotides and exon 2 containing an exonic enhancer. Spliceosome assembly assays were performed as described previously 55 56 with an oligonucleotide targeting U2 snRNA (position 1-14) 57 . Nuclear extracts from HeLa Flp-In cells were prepared as described previously 58 . Expression and purification of recombinant peptides. The optimized cDNAs were cloned in pEMT-11 vector to facilitate the expression of His-tagged SRRM3/4-derived peptides. The vectors were transformed in BL21 DE3 bacterial strain. Then, one colony was grown overnight in 10 ml Luria broth culture under antibiotic selection. The culture was diluted in 200 ml and the induction of expression was started at an absorbance of 0.6 at 600-nm wavelength with 1 mM isopropyl β-d-1-thiogalactopyranoside for 4 h at 37 °C. The cells were sedimented and resuspended in 1 ml CelLytic B Cell Lysis buffer (Sigma-Aldrich) supplemented with 0.4 mg ml −1 lysozyme. The samples were incubated for 20 min at room temperature, sonicated for 10 min (30 s on and 30 s off cycles; Bioruptor) and centrifuged for 20 min at 13,000 r.p.m. at 4 °C. Some 7.5 ml of buffer A (50 mM Tris pH 8.0, 500 mM NaCl and 1% Triton-X 100) and 1.5 ml slurry TALON Metal Affinity Resin (BD Biosciences) were added to the supernatant and incubated for 45 min with rotation at 4 °C. Beads were sedimented and washed three times with 8 ml buffer A and once with 8 ml buffer A without Triton-X 100, and eluted with 500 mM imidazole in buffer A without Triton-X 100. Fractions were analysed on a 15% SDS polyacrylamide gel electrophoresis by Coomassie staining. The most concentrated fraction was dialysed against buffer D (20 mM HEPES-KOH 8.0, 20% glycerol, 0.2 mM EDTA, 150 mM KCl and 1 mM DTT), and the protein concentration was estimated by Bradford quantification.
Generation of HeLa
MS2-MBP was expressed in BL21 DE3 cells. After centrifugation of the induced cells, the pellet was resuspended in 20 mM Tris-HCl pH 7.6, 200 mM NaCl and complete EDTA-free protease inhibitor tablet, and sonicated. After centrifugation, the supernatant was incubated with amylose resin pre-equilibrated in the same buffer for 2 h with rotation at 4 °C. The resin was washed with 20 mM HEPES-KOH pH 7.9, 150 mM NaCl and 0.05% NP-40, and the protein was eluted with 5 mM Na 2 HPO 4 and 15 mM maltose. The eluate was loaded onto a Heparin Sepharose column (Amersham). The beads were then washed with 5 mM Na 2 HPO 4 and eluted with 20 mM HEPES-KOH pH 7.9, 100 mM KCl, 15% glycerol, 0.5 mM DTT and 0.2 mM phenylmethylsulfonyl fluoride.
Purification of the RNP associated with the apbb1 substrate. To allow the formation of protein-RNA complexes, 6 µg of RNA bearing 3 MS2 stem loops at their 3′ end were boiled for 1 min, cooled on ice for 5 min, mixed with 20-fold excess of MS2-MBP recombinant protein in 20 mM HEPES-KOH pH 7.9 and further incubated for 30 min on ice. The complexes were then mixed with HeLa cell nuclear extracts (Cilbiotech) in a final volume of 250 µl containing 24 mM HEPES-KOH pH 7.9, 65 mM KCl, 0.0024 mM MgCl 2 , 2 mM ATP, 20 mM creatine phosphate and 40% nuclear extracts, complemented or not with 875 ng His-tagged C3 peptide (3.5 ng µl −1 ), and incubated for 9 min at 30 °C. From this, 240 µl were loaded on a 4 ml 10-30% glycerol gradient (in Beckman Coulter Polypropylene ultracentrifugation tubes) and run for 3 h at 55,000 r.p.m. (SW 60 Ti Rotor). The gradient was fractionated in three parts (top, middle and bottom). The middle and bottom parts were mixed and incubated with 90 µl slurry amylose resin (NEB) pre-equilibrated in 20 mM HEPES-KOH pH 7.9 and 200 mM NaCl. The samples were incubated with rotation for 10 min at 4 °C. Then, the beads were washed five times with 1 ml of 20 mM HEPES-KOH pH 7.9, 0.05% NP-40 and 150 mM NaCl, and eluted with 12 mM maltose added to this last buffer. Eluted proteins were precipitated in ethanol for 20 min at −20 °C and centrifuged at 13,000 r.p.m. for 30 min at 4 °C. One-third of the precipitated proteins were loaded on a 10% SDS polyacrylamide gel electrophoresis instrument and silver stained using the SilverQuest Silver Staining kit (Invitrogen). The remaining two-thirds of each replicate were sent for liquid chromatography-tandem mass spectrometry analysis for identification at the CRG Proteomics Unit. The sequences of the peptides were added in the search for identification and quantification.
RNP mass spectrometry acquisition. Samples were analysed using an LTQOrbitrap Velos Pro mass spectrometer (Thermo Fisher Scientific) coupled to an Easy-nLC (Thermo Fisher Scientific (Proxeon)). Peptides were loaded onto a 2 cm pre-column and separated by reverse-phase chromatography using a 25 cm column with an inner diameter of 75 μm, packed with 5 μm C18 particles (Nikkyo Technos). Chromatographic gradients started at 97% buffer A and 3% buffer B Articles NaTuRe eCology & evoluTIoN with a flow rate of 300 nl min −1 , and gradually increased to 93% buffer A and 7% buffer B after 1 min, and to 65% buffer A and 35% buffer B after 60 min. After each analysis, the column was washed for 10 min with 10% buffer A and 90% buffer B. Buffer A was 0.1% formic acid in water. Buffer B was 0.1% formic acid in acetonitrile.
The mass spectrometer was operated in positive ionization mode with the nanospray voltage set to 2.2 kV and a source temperature of 250 °C. Ultramark 1621 was used for external calibration of the Fourier transform mass analyser before the analyses. Moreover, an internal calibration was also performed using the background polysiloxane ion signal at m/z 445-1,200. The instrument was operated in DDA mode and full mass spectroscopy scans with 1 micro scan at a resolution of 60,000 were used over a mass range of m/z 350-2,000 with detection in the Orbitrap. Auto gain control was set to 1 × 10 6 with dynamic exclusion (60 s), and charge state filtering disqualifying singly charged peptides was activated. In each cycle of DDA analysis, following each survey scan, the top ten most intense ions with multiple charged ions above a threshold ion count of 5,000 were selected for fragmentation at a normalized collision energy of 35%. Fragment ion spectra produced via collision-induced dissociation were acquired in the ion trap. Auto gain control was set to 5 × 10 4 , with an isolation window of 2.0 m/z, an activation time of 0.1 ms and a maximum injection time of 100 ms. All data were acquired with Xcalibur software version 2.2.
RNP mass spectrometry data analysis. Raw tandem mass spectrometry files were processed using Proteome Discoverer version 1.4 (Thermo Fisher Scientific). Peak lists were searched using Mascot software version 2.5.1 (Matrix Science) against the human Swiss-Prot database (April 2017 version) containing 20,797 protein entries, a list of 600 common contaminants and all of the corresponding decoy entries. The precursor ion mass tolerance was set to 7 ppm, and the fragment ion mass tolerance was set to 0.5 Da. Up to three missed cleavages were allowed, and oxidation (M) and acetylation (protein N terminal) were defined as variable modifications, whereas carbamidomethylation (C) was set as a fixed modification. SAINTexpress version 3.6.1 (ref. 54 ) was used as a statistical tool to calculate the probability value of each potential interaction compared with background samples with no RNA, requiring a minimum of two unique peptides. Each biological replicate was analysed independently against no-RNA controls before averaging the score values and assessing the Bayesian FDRs (Supplementary Dataset 5) 54 . Highconfidence interactions are those with FDR ≤ 1%. For Fig. 4g and Supplementary  Fig. 4b-d , background (that is, no-RNA samples) numbers of spectral counts were subtracted from the average spectral counts between replicates, and the log 2 [foldchange enrichment] between each pair of conditions was calculated.
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Data collection
Gel images were obtained using the following software: GelDoc (BioRad), Amesharm 6000 Imager and Typhoon TRIO Variable Mode Imager Quantitative-PCR data was generated using LightCycler 480 software (Roche) Mass spectrometry data was obtained using Xcalibur software v2.2 Flow cytometry data acquisition is described on a separate section
Data analysis
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Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research Laboratory animals Nematostella vectensis individuals used for RNA-seq come from strain CH2 males and CH6 females. Generation of the transgenic line NvElav1::mOrange was described elsewhere (Nakanishi et al 2012) . This is a non-vertebrate animal and thus it does not require ethical approvals.
Wild animals
Mixed male and female individuals of Strigamia maritima used for RNA-seq were a gift of the lab of Michael Akam (Univ. of Cambridge)
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